Please ensure Javascript is enabled for purposes of website accessibility

Got $5,000? 5 of the Best Buffett Stocks to Buy Now

By Sean Williams - Feb 5, 2021 at 5:06AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Riding the Oracle of Omaha's coattails has historically been a smart move.

When it comes to investing greats, Warren Buffett is arguably in a class of his own. Since the 1950s, the Oracle of Omaha grew his net worth from $10,000 to north of $88 billion. Mind you, this $88 billion figure doesn't include the $37 billion he's generously donated to charitable organizations over the past 14 years.

He's also done quite well for Berkshire Hathaway's (BRK.A 1.69%) (BRK.B 1.64%) shareholders as the company's CEO. Between 1965 and 2019, Berkshire delivered an average annual return of 20.3%. That works out to an aggregate gain of 2,744,062%, which created over $400 billion in value for the company's investors.

Long story short, when Buffett buys and holds a stock, investors tend to pay close attention.

Right now, five Buffett stocks stand out as particularly attractive. If you have, say, $5,000 in investable capital that won't be needed to pay bills or cover emergencies, you should consider putting that money to work in the following brand-name companies.

Warren Buffett at his company's annual shareholder meeting.

Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.


Even though it was added to Berkshire Hathaway's portfolio by one of Buffett's investing lieutenants (Todd Combs or Ted Weschler), e-commerce kingpin Amazon (AMZN 3.15%) has all the makings of a core portfolio holding that still offers significant long-term upside.

You're likely familiar with Amazon because of its leading online marketplace. Amazon controls between 39% and 44% of all e-commerce in the United States (estimates vary depending on your source). That's well over 30 percentage points higher than the next-closest competitor. Despite retail margins being nothing to write home about, Amazon has been able to turn its retail popularity into well over 150 million global Prime subscriptions. Each and every one of these subscriptions incentivizes members to stay within Amazon's ever-growing product, content, and services ecosystem.

The real driving force behind Amazon's long-term growth story is Amazon Web Services (AWS). AWS is the company's cloud infrastructure service, and it grew by a healthy 30% in 2020 despite the worst economic downturn in decades. Whereas Amazon generated just shy of $9.4 billion in operating income on $341 billion in sales from its other operating segments, AWS was responsible for $13.5 billion in operating income on $45 billion in sales. Put simply, as AWS becomes a larger part of total sales, Amazon's cash flow will catapult higher

A lab technician holding a vial of blood in his left hand while reading from a clipboard in his right hand.

Image source: Getty Images.

Bristol Myers Squibb

Brand-name healthcare stocks are usually great ways to put your money to work. Since people don't get to choose when or how they get sick, there tends to be a steady level of demand for drugs and devices, no matter how well or poorly the economy is performing. That's why value stock Bristol Myers Squibb (BMY -0.21%) is such a great buy right now.

There's no question that some of Bristol Myers' momentum is coming from its acquisition of Celgene, which it completed in November 2019. This deal brought blockbuster cancer drug Revlimid into the fold. For more than a decade, Revlimid's sales have rocketed higher on the heels of increased duration of use and multiple label expansions. Best of all, long before it was acquired, Celgene arranged for Revlimid to be protected from a flood of generic competition until early 2026. That gives Bristol Myers Squibb a five-year runway to pile on the cash flow for a drug that will likely top $12 billion in annual sales.

There's also plenty to like in the organic pipeline. Eliquis continues to be the top-selling oral anticoagulant in the world, and cancer immunotherapy Opdivo offers numerous label expansion opportunities. Opdivo is already generating about $7 billion in sales annually, and could potentially top $10 billion if future clinical studies bear fruit.

A person using their smartphone to make a touch pay digital transaction.

Image source: Bank of America.

Bank of America

Warren Buffett loves bank stocks. At the tippy-top of the Oracle of Omaha's list of buys in the financial sector is Bank of America (BAC 1.38%).

Admittedly, bank stocks are currently facing a number of challenges. This includes historically low interest rates (which hurt interest income-earning potential) and rising delinquency rates tied to the coronavirus recession. Nevertheless, history has proved time and again that buying bank stocks toward the end of a recession is almost always a smart move.

Bank of America is the most interest-sensitive of the big banks. While lending rates aren't likely to rise considerably before 2024, BofA will be in line to see the biggest boost to interest income when the economy comes roaring back and interest rates do begin ticking higher.

Bank of America has also done a solid job of controlling expenses by consolidating some of its branches and investing heavily in digitization. It's considerably cheaper for BofA to handle transactions online and through its mobile app than in person or by phone. It's ongoing shifts like this that will make BofA more profitable and allow for hearty capital return programs.

A person pressing a button on a Sirius XM in-car dashboard.

Image source: Sirius XM.

Sirius XM

Another Buffett stock that just seems to get better with age is satellite-radio operator Sirius XM (SIRI 1.30%).

Not only is Sirius XM a legal monopoly, but it brings a significant competitive advantage to the table that virtually no other terrestrial and online radio operators can offer. Whereas terrestrial and online radio almost exclusively rely on advertising revenue to drive top- and bottom-line growth, Sirius XM generates almost 80% of its revenue from subscriptions to its satellite radio service. Subscribers are far less likely to cancel their service during an economic downturn than advertisers are to reduce their spending. As a result, Sirius XM finds itself in much better shape during downturns than its peers. 

Something else for investors to consider is that Sirius XM operates a partially fixed-cost business. Though revenue sharing and talent acquisition costs can vary, the company's transmission and equipment costs are predominantly fixed no matter how many new subscribers it signs up. That's a recipe for steadily growing operating margins over the long run.

A smiling woman holding up a credit card in her right hand, with an open laptop on the table in front of her.

Image source: Getty Images.


Lastly, one of the best Buffett stocks you can buy with $5,000 is payment facilitator Visa (V 1.16%).

As you might imagine, Visa is a cyclical company that counts on an expanding U.S. and global economy to grow. The coronavirus recession threw a monkey wrench into its 10-year streak of increasing credit card purchasing volume traversing its network. But the good news here is that periods of expansion usually last for many years, whereas recessions are measured in quarters.

Visa is the unquestioned dominant player in the U.S. -- the biggest market for consumption in the world. Between 2009 and 2018, Visa's share of credit card network purchase volume grew by more than 9 percentage points to 53%. That's over 30 percentage points higher than its next-closest competitor, Mastercard.

It's also a company that's resisted the urge to lend. By strictly sticking to payment facilitation and avoiding lending, Visa doesn't have to worry about any increases in loan delinquencies when recessions arise. Not having to set aside capital for loan/credit losses is precisely why Visa's profit margin hovers at or above 50%.

Currently down 7% in 2021, Visa is begging to be charged by long-term investors.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Visa Inc. Stock Quote
Visa Inc.
$199.18 (1.16%) $2.29
Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
$415,850.00 (1.69%) $6,900.00
Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
$277.50 (1.64%) $4.48
Bank of America Corporation Stock Quote
Bank of America Corporation
$31.56 (1.38%) $0.43, Inc. Stock Quote, Inc.
$109.56 (3.15%) $3.35
Bristol Myers Squibb Company Stock Quote
Bristol Myers Squibb Company
$76.84 (-0.21%) $0.16
Sirius XM Holdings Inc. Stock Quote
Sirius XM Holdings Inc.
$6.21 (1.30%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.